Subscribe to the SLI Medical mailing list to receive updates on new arrivals, special offers and our promotions.
The store will not work correctly in the case when cookies are disabled.
Get Up to 25% OFF PPE MasksGowns * Limited time only.
SLI MEDICAL IS A WHOLESALE SITE! WE ONLY SELL TO QUALIFIED FACILITIES (Such As Hospitals, Physician Offices, & Distributors). All Addresses are Verified.
Infanrix® DTaP Vaccine Indicated for People 6 Weeks to 7 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed Injection Prefilled Syringe 0.5 mL
Bexsero® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
Menveo® Meningitis Vaccine Indicated for People 2 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 m
and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
Strength
Preservative Free
Type
58160095509
UNSPSC Code
SLI Medical Acceptable Dating: we will ship >= 90 days
User
Requires Refrigeration
Volume
10 mcg - 5 mcg / 0.5 mL
Intramuscular
51201610
Indicated for People 2 Months Through 55 Years of Age
0.5 mL
Features
MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A
C
Y
and W-135. MENVEO is approved for use in persons 2 months through 55 years of age
MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration
Menveo® Meningitis Vaccine Indicated for People 2 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 m
